Outpost Unveils Space Factories: Standardized Orbital Manufacturing and Reentry
Outpost Technologies launches its 'Space Factories' program, offering turnkey orbital production and return services to bypass the logistical hurdles of the ISS and traditional spacecraft development.
Terminal Access: Orbital Infrastructure Update
Outpost Technologies Corporation has officially transitioned from reentry specialist to full-service orbital provider with the launch of Space Factories. This new program offers a standardized manufacturing environment within the company’s "CarryAll" Earth return vehicles, designed to remove the hardware barrier for companies seeking microgravity production. According to Payload, the service targets high-value sectors including pharmaceuticals, semiconductors, and advanced crystals.
The Turnkey Edge
Outpost President Amir Blachman highlighted the shift toward infrastructure-as-a-service, stating that organizations should not have to become spacecraft manufacturers to utilize orbital physics. By providing power, thermal management, and a dedicated reentry path, Outpost simplifies the supply chain from launch to lab. The program aims to move beyond the limitations of the International Space Station (ISS), where human safety protocols and astronaut schedules often hinder high-energy or off-gassing manufacturing processes.
Industrial Roadmap
Outpost will act as the inaugural client for its own platform. The company plans to manufacture StarFiber—a next-generation metal fluoride optical fiber—on a mission scheduled no earlier than (NET) 2028. Produced in microgravity to eliminate Earth-bound defects like signal loss, StarFiber represents the prototype for scalable in-space fabrication.
The hardware is designed for versatility. The Space Factory modules will fit within the CarryAll vehicle, offering production capacities ranging from shoebox-sized units to the Block 3 variant’s 33 cubic meters. With the ISS deorbit looming in the early 2030s, Outpost is positioning its autonomous "free flyer" system as the primary successor for pharmaceutical and life science industries seeking rapid, automated Earth return.